The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support


  • Delphine Staumont-Sallé
  • Charles Taieb Patient Priority Department, European Market Maintenance Assessment, FR-94120 Fontenay sous Bois, France
  • Stephanie Merhand
  • Jason Shourick



atopic dermatitis, Atopic Dermatitis Control Tool, patient centricity


The evaluation of global atopic dermatitis control is key to minimizing disease burden. The Atopic Dermatitis Control Tool (ADCT) has been developed for this purpose. Participants (diagnosed by a physician) were recruited to this observational cross-sectional study using real-life methodology and completed a questionnaire on sociodemographic and personal information. The ADCT algorithm, described by Pariser, was used to categorize patients as having controlled or uncontrolled atopic dermatitis. Data were collected for 1,606 patients. Median age of the patients was 40 years , and 1,023 (63.7%) patients were women. A total of 1,146 (71.4%) patients had uncontrolled atopic dermatitis according to the ADCT score. Patients with uncontrolled disease were at significantly higher risk of a high stress level and were more likely to be absent from work than those with controlled disease. In conclusion, a key factor for predicting disease burden in atopic dermatitis is patient self-assessed disease control in terms of multiple dimensions: stress, sleep, quality of life, work absenteeism and loss of productivity.


Download data is not yet available.


Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol 2017; 137: 18-25. DOI:

Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Knol EF, et al. Serum biomarker profiles suggest that atopic dermatitis is a systemic disease. J Allergy Clin Immunol 2018; 141: 1523-1526. DOI:

Oliveira C, Torres T. More than skin deep: the systemic nature of atopic dermatitis. Eur J Dermatol EJD 2019; 29: 250-258.

Bylund S, Kobyletzki L, Svalstedt M, Svensson. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol 2020; 100: adv00160. DOI:

Richard M-A, Corgibet F, Beylot-Barry M, Barbaud A, Bodemer C, Chaussade V, et al. Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study. J Eur Acad Dermatol Venereol 2018; 32: 1967-1971. DOI:

Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. The Lancet 2020; 396: 345-360. DOI:

Koszorú K, Borza J, Gulácsi L, Sárdy M. Quality of life in patients with atopic dermatitis. Cutis 2019; 104: 174-177.

Kage P, Simon J, Treudler R. Atopic dermatitis and psychosocial comorbidities. J Dtsch Dermatol Ges 2020; 18: 93-102. DOI:

Girolomoni G, Gadkari A, Auziere S, Puig L, Barbarot S, Chosidow O, et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Canada and Europe. Value Health 2017; 20: A807. DOI:

Chang Y-S, Chiang B-L. Sleep disorders and atopic dermatitis: a 2-way street? J Allergy Clin Immunol 2018; 142: 1033-1040. DOI:

Mann C, Dreher M, Weeß H-G, Staubach P. Sleep disturbance in patients with urticaria and atopic dermatitis: an underestimated burden. Acta Derm Venereol 2020; 100: adv00073. DOI:

Lin T-K, Zhong L, Santiago JL. Association between stress and the HPA axis in the atopic dermatitis. Int J Mol Sci 2017; 18: 2131. DOI:

Suárez AL, Feramisco JD, Koo J, Steinhoff M. Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol 2012; 92: 7-15. DOI:

Chung J, Simpson EL. The socioeconomics of atopic dermatitis. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol 2019; 122: 360-366. DOI:

Ariëns LFM, van Nimwegen KJM, Shams M, de Bruin DT, van der Schaft J, van Os-Medendorp H, et al. Economic burden of adult patients with moderate to severe atopic dermatitis indicated for systemic treatment. Acta Derm Venereol 2019; 99: 762-768. DOI:

Stróżek J, Samoliński BK, Kłak A, Gawińska-Drużba E, Izdebski R, Krzych-Fałta E, et al. The indirect costs of allergic diseases. Int J Occup Med Environ Health 2019; 32: 281-290. DOI:

Le PH, Vo TQ. Economic burden and productivity loss related to eczema: a prevalence-based follow-up study in Vietnam. JPMA J Pak Med Assoc 2019; 69: S57-S63.

Simpson E, Eckert L, Gadkari A, Mallya UG, Yang M, Nelson L, et al. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. BMC Dermatol 2019; 19: 15. DOI:

Pariser DM, Simpson EL, Gadkari A, Bieber T, Margolis DJ, Brown M, et al. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Curr Med Res Opin 2020; 36: 367-376. DOI:

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. DOI:

Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664. DOI:

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385. DOI:

Paradis, Bénédicte 2020-03-03) Comparaison du niveau de stress en fonction du profil social et académique des étudiants rennais en première année de licence,/Université de Rennes 1.

Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004; 140: 1513-1519. DOI:

Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol 2013; 169: 1326-1332. DOI:

Institute of Medicine (US) Council on Health Care Technology; Mosteller F, Falotico-Taylor J, editors. Quality of life and technology assessment: monograph of the Council on Health Care Technology. Washington (DC): National Academies Press (US); 1989. 6, Assessing quality of life: measures and utility. [accessed 1 August 2021] Available from:

Ridd MJ, King AJL, Le Roux E, Waldecker A, Huntley AL. Systematic review of self-management interventions for people with eczema. Br J Dermatol 2017; 177: 719-734. DOI:

Glazer AM, Rigel DS. Analysis of trends in geographic distribution of US dermatology workforce density. JAMA Dermatol 2017; 153: 472. DOI:

Parcours des patients insuffisants cardiaques sévères, Arrêté Dirnov -2019/13, Agence régionale de santé IDF.




How to Cite

Staumont-Sallé, D., Taieb, C., Merhand, S., & Shourick, J. (2021). The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support. Acta Dermato-Venereologica, 101(12), adv00618.